Updated: Feb 4, 2020
KRas Kickers will be attending the 2020 National Lung Cancer Roundtable to represent the 25% of the lung cancer patients with a Kirsten rat sarcoma (KRAS) mutation. A comprehensive biomarker test should be completed by a doctor to identify cancer mutations.
Three of the four most deadly U.S. cancers (lung, colon and pancreatic) have a KRAS mutation. There are no specific drugs for KRAS cancers, more research is crucial.
KRasKickers.org is a patient driven conduit advocating for treatments, sharing knowledge & clinical trials for KRAS lung cancer patients pleading to Kick Cancers K Ras!!